Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer.
Saved in:
| Title: | Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer. |
|---|---|
| Authors: | Elakad O; Institute of Pathology, University Medical Center, Goettingen, Germany., Häupl B; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.; German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Labitzky V; Institute for Anatomy and Experimental Morphology, University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Yao S; Institute of Pathology, University Medical Center, Goettingen, Germany., Küffer S; Institute of Pathology, University Medical Center, Goettingen, Germany., von Hammerstein-Equord A; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Goettingen, Germany., Danner BC; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Goettingen, Germany., Jücker M; Center for Experimental Medicine, Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Urlaub H; Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Goettingen, Germany., Lange T; Institute for Anatomy and Experimental Morphology, University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ströbel P; Institute of Pathology, University Medical Center, Goettingen, Germany., Oellerich T; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.; German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Bohnenberger H; Institute of Pathology, University Medical Center, Goettingen, Germany. Hanibal.bohnenberger@med.uni-goettingen.de. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2022 Jul 19; Vol. 6 (1), pp. 52. Date of Electronic Publication: 2022 Jul 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35853934 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Elakad+O%22">Elakad O</searchLink>; Institute of Pathology, University Medical Center, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22Häupl+B%22">Häupl B</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.; German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Labitzky+V%22">Labitzky V</searchLink>; Institute for Anatomy and Experimental Morphology, University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Yao+S%22">Yao S</searchLink>; Institute of Pathology, University Medical Center, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22Küffer+S%22">Küffer S</searchLink>; Institute of Pathology, University Medical Center, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22von+Hammerstein-Equord+A%22">von Hammerstein-Equord A</searchLink>; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22Danner+BC%22">Danner BC</searchLink>; Department of Thoracic and Cardiovascular Surgery, University Medical Center, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22Jücker+M%22">Jücker M</searchLink>; Center for Experimental Medicine, Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Urlaub+H%22">Urlaub H</searchLink>; Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lange+T%22">Lange T</searchLink>; Institute for Anatomy and Experimental Morphology, University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ströbel+P%22">Ströbel P</searchLink>; Institute of Pathology, University Medical Center, Goettingen, Germany.<br /><searchLink fieldCode="AU" term="%22Oellerich+T%22">Oellerich T</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.; German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Bohnenberger+H%22">Bohnenberger H</searchLink>; Institute of Pathology, University Medical Center, Goettingen, Germany. Hanibal.bohnenberger@med.uni-goettingen.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2022 Jul 19; Vol. 6 (1), pp. 52. <i>Date of Electronic Publication: </i>2022 Jul 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35853934 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41698-022-00296-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 52 Titles: – TitleFull: Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Elakad O – PersonEntity: Name: NameFull: Häupl B – PersonEntity: Name: NameFull: Labitzky V – PersonEntity: Name: NameFull: Yao S – PersonEntity: Name: NameFull: Küffer S – PersonEntity: Name: NameFull: von Hammerstein-Equord A – PersonEntity: Name: NameFull: Danner BC – PersonEntity: Name: NameFull: Jücker M – PersonEntity: Name: NameFull: Urlaub H – PersonEntity: Name: NameFull: Lange T – PersonEntity: Name: NameFull: Ströbel P – PersonEntity: Name: NameFull: Oellerich T – PersonEntity: Name: NameFull: Bohnenberger H IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 07 Text: 2022 Jul 19 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2397-768X Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: NPJ precision oncology Type: main |
| ResultId | 1 |